Ramu A, Fusner J E, Blaschke T, Glaubiger D L
Cancer Treat Rep. 1978 Oct;62(10):1465-70.
Cerebrospinal fluid (CSF) and plasma concentrations of methotrexate (MTX) were followed in dogs for 72 hours after intracisternal injection of MTX with and without probenecid pretreatment. CSF levels declined as a biexponential function of time. Probenecid pretreatment of the animals prolonged the second phase half-disappearance time of MTX from 5.20 +/- 0.89 to 7.086 +/- 0.23 hours (mean +/- SD). The peak mean plasma concentration of MTX was lower in the presence of probenecid. Also, the rate of decline of plasma MTX concentrations was slower after treatment with probenecid, with mean half-disappearance times of 7.60 +/- 0.77 and 11.32 +/- 1.08 hours. These CSF and plasma data support the proposal that probenecid inhibits the transfer of MTX from CSF to blood.
在狗脑池内注射甲氨蝶呤(MTX)后,观察了有无丙磺舒预处理情况下狗的脑脊液(CSF)和血浆中甲氨蝶呤(MTX)的浓度变化,持续72小时。脑脊液水平随时间呈双指数函数下降。动物经丙磺舒预处理后,MTX的第二阶段半衰期从5.20±0.89小时延长至7.086±0.23小时(平均值±标准差)。丙磺舒存在时,MTX的血浆平均峰值浓度较低。此外,丙磺舒治疗后血浆MTX浓度的下降速率较慢,平均半衰期分别为7.60±0.77小时和11.32±1.08小时。这些脑脊液和血浆数据支持丙磺舒抑制MTX从脑脊液向血液转移的观点。